Regulatory Strategy & Submissions
White Paper
Final FDA Guidance – Post-Market Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act
Get Your Copy Now Name(Required) First Name Last Name Company name(Required)Email(Required) Consent(Required) By checking here, you agree for the information...
White Paper
Changes to Medical Device Regulations in China
Get Your Copy Now Name(Required) First Name Last Name Company name(Required)Email(Required) Consent(Required) By checking here, you agree for the information...
White Paper
Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications
The FDA confirms that the potential benefit of a medical device outweighs the potential risk before they will approve the device. The FDA considers several…